Autoantibodies and other biomarkers – pathological consequences (1)

1 Miyakis S Lockshin MD Atsumi T . International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295 – 306 .

2 Giles IP Haley JD Nagl S Isenberg DA Latchman DS Rahman A . A systematic analysis of sequences of human antiphospholipid and anti-beta2-glycoprotein I antibodies: the importance of somatic mutations and certain sequence motifs. Semin Arthritis Rheum 2003; 32: 246 – 265 .

3 Pierangeli SS Liu X Espinola R . Functional analyses of patient-derived IgG monoclonal anticardiolipin antibodies using in vivo thrombosis and in vivo microcirculation models. Thromb Haemost 2000; 84: 388 – 395 .

4 Chukwuocha R; Zhu M; Cho C; . Molecular and genetic characterizations of five pathogenic and two non-pathogenic monoclonal antiphospholipid antibodies. Mol Immunol 2002; 39: 299–311.

5 Giles I Haley J Nagl S . Relative importance of different human aPL derived heavy and light chains in the binding of aPL to cardiolipin. Mol Immunol 2003; 40: 49 – 60 .

6 Giles I Lambrianedes N Latchman D . The critical role of arginine residues in the binding of human antiphospholipid antibodies to cardiolipin. Arthritis Res Ther 2005; 7: R47 – R56 .

7 Giles I Lambrianides N Pattni N . Arginine residues are important in determining the binding of human monoclonal antiphospholipid antibodies to clinically relevant antigens. J Immunol 2006; 177: 1729 – 1736 .

8 Giles I Liu X Newton-West M . The light chain of a human monoclonal antiphospholipid antibody has a dramatic influence on its functional properties in an in vivo mouse model. Arthritis Rheum 2006; 54: S559 .

9 Wakeland EK Liu K Graham RR Behrens TW . Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001; 15: 397 – 408 .

10 Bygrave AE Rose KL Cortes-Hernandez J . Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol 2004; 2: E243 .

11 Carlucci F Cortes-Hernandez J Fossati-Jimack L . Genetic dissection of spontaneous autoimmunity driven by 129-derived chromosome 1 Loci when expressed on C57BL/6 mice. J Immunol 2007; 178: 2352 – 2360 .

12 Chen C Nagy Z Prak EL Weigert M . Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity 1995; 3: 747 – 755 .

13 Prak EL Weigert M . Light chain replacement: a new model for antibody gene rearrangement. J Exp Med 1995; 182: 541 – 548 .

14 Sekiguchi DR Jainandunsing SM Fields ML . Chronic graft-versus-host in Ig knockin transgenic mice abrogates B cell tolerance in anti-double-stranded DNA B cells. J Immunol 2002; 168: 4142 – 4153 .

15 Ben-Yehuda A Rasooly L Bar-Tana R . The urine of SLE patients contains antibodies that bind to the laminin component of the extracellular matrix. J Autoimmun 1995; 8: 279 – 291 .

16 Amital H Heilweil M Ulmansky R . Treatment with a laminin-derived peptide suppresses lupus nephritis. J Immunol 2005; 175: 5516 – 5523 .

17 Qing X Zavadil J Crosby MB . Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum 2006; 54: 2198 – 2210 .

18 Boule MW Broughton C Mackay F Akira S Marshak-Rothstein A Rifkin IR . Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004; 199: 1631 – 1640 .

19 Lau CM Broughton C Tabor AS . RNA-associated autoantigens activate B cells by combined B cell antigen receptor/toll-like receptor 7 engagement. J Exp Med. 2005; 202: 1171 – 1177 .

20 Rifkin IR Leadbetter EA Busconi L Viglianti G Marshak-Rothstein A . Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev 2005; 204: 27 – 42 .

21 Christensen SR Shupe J Nickerson K Kashgarian M Flavell RA Shlomchik MJ . Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006; 25: 417 – 428 .

22 Christensen SR Shlomchik MJ . Regulation of lupus-related autoantibody production and clinical disease by toll-like receptors. Semin Immunol 2007; 19: 11–23.

23 Means TK Latz E Hayashi F Murali MR Golenbock DT Luster AD . Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 2005; 115: 407 – 417 .

24 Mishra J Ma Q Kelly C . Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 2006; 21: 856 – 863 .

25 Mishra J Mori K Ma Q . Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 2004; 15: 3073 – 3082 .

26 Mishra J Ma Q Prada A . Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003; 14: 2534 – 2543 .

27 Mishra J Mori K Ma Q Kelly C Barasch J Devarajan P . Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol 2004; 24: 307 – 315 .

28 Mishra J Dent C Tarabishi R . Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231 – 1238 .

29 Mitsnefes MM Kathman TS Mishra J . Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol 2007; 22: 101 – 108 .

30 Mori K Lee HT Rapoport D . Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 2005; 115: 610 – 621 .

31 Parikh CR Jani A Mishra J . Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006; 6: 1639 – 1645 .

32 Brunner HI Mueller M Rutherford C . Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2577 – 2584 .

33 Pitashny M Pressler-Schwartz N Qing X . Urinary lipocalin-2 as a potential biomarker for human lupus nephritis. Arthritis Rheum 2007; 56: 1894 – 1903 .